Skip to main content
logo
Adverum Biotechnologies, Inc. (ADVM)
Dec 9, 2025 - ADVM was delisted (reason: acquired by LLY)
4.360
+0.100 (2.35%)
Inactive · Last trade price on Dec 8, 2025

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2021FY 2019FY 20182010 - 2017
Period Ending
Dec '24 Dec '23 Dec '21 Dec '19 Dec '18 2010 - 2017
Gene Therapeutics
1.00M
Log In
Log In
Log In
Log In
Upgrade
Gene Therapeutics Growth
-72.22%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2021FY 2019FY 20182010 - 2017
Period Ending
Dec '24 Dec '23 Dec '21 Dec '19 Dec '18 2010 - 2017
United States
1.00M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-72.22%
Log In
Log In
Log In
Log In
Upgrade